Patent Issued for Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions (USPTO 11931459).

Pacira Pharmaceuticals Inc. has been issued a patent for the treatment of pain in pediatric patients using sustained-release liposomal anesthetic compositions. The patent describes a method of administering a pharmaceutical composition containing bupivacaine to pediatric patients to manage pain without the use of opioids. The invention aims to provide effective pain management for children undergoing surgery, as uncontrolled pain can lead to complications and prolonged healing. The patent includes specific dosage and administration instructions for different age groups and surgical procedures. [Extracted from the article]

Copyright of Pain & Central Nervous System Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)